Ann: FDA Regulatory Progress Update, page-3

I also find myself somewhat buoyed by recent events - both progress on the FDA approval and composition of new board and management.
Re funding - I wonder if we qualify for government commercialisation assistance in bringing novel products and processes to market.
Not sure whether I would subscribe to another shareholder issue as I am hugely overweight this one based on funds I've invested - based on market value, it would be a no-brainer.

dyor